{
  "id": 14672676,
  "title": "Zymeworks Announces Participation in Upcoming Investor Conferences and Date of Third Quarter 2026 Financial Results",
  "url": "https://urgent.news/2026/10/15/zymeworks-announces-participation-in-upcoming-investor-conferences",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-10-15T10:04:57.000Z",
  "source": {
    "name": "Financial Post",
    "slug": "financial-post",
    "url": "https://financialpost.com/globe-newswire/zymeworks-announces-participation-in-upcoming-investor-conferences-and-date-of-third-quarter-2026-financial-results"
  },
  "original_language": "en",
  "account": null,
  "summary": "Zymeworks to Report Third Quarter 2026 Financial Results on November 9, 2026 VANCOUVER, British Columbia, Oct. 15, 2026 (GLOBE NEWSWIRE) — Zymeworks Inc. (Nasdaq: ZYME), a biotechnology company managing a portfolio of licensed healthcare assets while developing a diverse pipeline of novel, multifunctional biotherapeutics, today announced that management will report its third quarter 2026…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Financial Post",
        "title": "illumin Holdings Inc. announces date for third quarter 2026 financial and operating results",
        "url": "https://urgent.news/2026/10/15/illumin-holdings-inc-announces-date-for-third-quarter-2026-financial",
        "published": "2026-10-15T11:14:18.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}